Global Small Molecule Cdmo Market Size & Outlook

The global small molecule cdmo market size was estimated at USD 71,339.0 million in 2024 and is projected to reach USD 126,210.3 million by 2033, growing at a CAGR of 6.7% from 2025 to 2033.
Revenue, 2024 (US$M)
$71,339.0
Forecast, 2033 (US$M)
$126,210.3
CAGR, 2025 - 2033
6.7%
Report Coverage
Worldwide

Global small molecule cdmo market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global small molecule cdmo market highlights

  • The global small molecule cdmo market generated a revenue of USD 71,339.0 million in 2024 and is expected to reach USD 126,210.3 million by 2033.
  • The market is expected to grow at a CAGR (2025 - 2033) of 6.7% by 2033.
  • In terms of segment, active pharmaceutical ingredients (api) accounted for a revenue of USD 46,588.0 million in 2024.
  • Active Pharmaceutical Ingredients (API) is the most lucrative product segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, Japan is expected to register the highest CAGR from 2025 to 2033.

Global data book summary

Market revenue in 2024USD 71,339.0 million
Market revenue in 2033USD 126,210.3 million
Growth rate6.7% (CAGR from 2025 to 2033)
Largest segmentActive pharmaceutical ingredients (api)
Fastest growing segmentActive Pharmaceutical Ingredients (API)
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationActive Pharmaceutical Ingredients (API), Finished Drug Products

Other key industry trends

  • In terms of revenue, the North America accounted for 40.9% of the global small molecule cdmo market in 2024.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
  • By country, Japan is the fastest growing regional market and is projected to reach USD 8,042.1 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Small Molecule CDMO Market Companies

Name Profile # Employees HQ Website
Aurigene Pharmaceutical Services View profile 501-1000 Bangalore, Karnataka, India, Asia https://www.aurigeneservices.com
Siegfried Holding AG View profile 4180 Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 https://www.siegfried.ch
Catalent Inc View profile 17219 14 Schoolhouse Road, Somerset, NJ, United States, 08873 https://www.catalent.com
Eurofins Scientific SE View profile 61798 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 https://www.eurofins.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com

Global small molecule cdmo market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to small molecule cdmo market will help companies and investors design strategic landscapes.


Active pharmaceutical ingredients (api) was the largest segment with a revenue share of 65.31% in 2024. Horizon Databook has segmented the Global small molecule cdmo market based on active pharmaceutical ingredients (api), finished drug products covering the revenue growth of each sub-segment from 2021 to 2033.


  • Global Small Molecule CDMO Product Outlook (Revenue, USD Million, 2021-2033)
    • Active Pharmaceutical Ingredients (API)
    • Finished Drug Products
  • Global Small Molecule CDMO Drug Type Outlook (Revenue, USD Million, 2021-2033)
    • Generics
    • Innovators
  • Global Small Molecule CDMO Application Outlook (Revenue, USD Million, 2021-2033)
    • Central Nervous System (CNS) Conditions
    • Autoimmune/Inflammation
    • Oncology
    • Cardiovascular Disease
    • Others

Reasons to subscribe to Global small molecule cdmo market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global small molecule cdmo market databook

  • Our clientele includes a mix of small molecule cdmo market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global small molecule cdmo market , including forecasts for subscribers. This global databook contains high-level insights into Global small molecule cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global small molecule cdmo market report size, by regions, 2021-2033 (US$M)

Top 10 countries: Small molecule cdmo market report size, 2024 (US$M)

Global small molecule cdmo market report share, by product, 2024 & 2033 (%, US$M)

Small molecule cdmo market: Opportunity assessment by country

Global small molecule cdmo market, by region, 2024 (US$M)

Global small molecule cdmo market report size, by regions, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online